The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for agilon health inc. (AGL) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.50, or 1.98%, to $25.72. The agilon health inc. has recorded 16,059 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that agilon health Reports Fourth Quarter and Fiscal Year 2022 Results.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
agilon health inc. is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Care Facilities industry. At the end of the last regular session, the stock closed at $25.22 and fluctuated between $25.81 as its day high and $24.51 as its day low. The current market capitalization of agilon health inc. is $10.08B. A total of 3.69 million shares were traded on the day, compared to an average of 2.02M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, AGL has seen 15 BUY and 13 SELL insider trades, representing the acquisition of 163,299 and the disposition of 157,901 shares. Over the last 12 months, there were 79 BUYs and 88 SELLs from insiders. Insiders purchased 1,875,709 shares during that period but sold 13,385,870.
In the most recent transaction, Shaker Benjamin sold 28,555 shares of AGL for 23.37 per share on Feb 15. After the transaction, the Chief Markets Officer now owns 25,625 company shares. In a previous transaction on Feb 15, Kornitzer Benjamin sold 8,094 shares at 22.98 per share. AGL shares that Chief Med. & Quality Officer owns now total 10,426.
Among the insiders who sold shares, Shaker Benjamin disposed of 50,000 shares on Feb 14 at a per-share price of $22.98. This resulted in the Chief Markets Officer holding 25,625 shares of AGL after the transaction. In another insider transaction, Kornitzer Benjamin sold 25,881 shares at $22.99 per share on Feb 14. Company shares held by the Chief Med. & Quality Officer now total 10,426.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for AGL in the last 3 months, the mean price target is $27.27 with high estimates of $33.00 and low estimates of $21.00. In terms of 52-week highs and lows, AGL has a high of $28.36 and a low of $14.82.
As of this writing, AGL has an earnings estimate of -$0.09 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.04 per share and a lower estimate of -$0.13. The company reported an EPS of -$0.05 in the last quarter, which was -150.00% lower than expectations of -$0.02.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 13 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGL is Hold with a score of 4.79. A total of 12 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.